Silver Book Fact

Multifocal electroretinogram (mFERG) and flicker perimetry show abnormal function in the central macula in early ag-related macular degeneration (AMD) and could enhance monitoring of the disease progression in individuals.

Gin T, Luu C, Guymer R. Central Retinal Function as Measured by the Multifocal Electroretinogram and Flicker Perimetry in AMD. Invest Opthalmol Vis Sci. 2011; 52(12): 9267-9274. https://iovs.arvojournals.org/article.aspx?articleid=2187859

Reference

Title
Central Retinal Function as Measured by the Multifocal Electroretinogram and Flicker Perimetry in AMD
Publication
Invest Opthalmol Vis Sci
Publication Date
2011
Authors
Gin T, Luu C, Guymer R
Volume & Issue
Volume 52, Issue 12
Pages
9267-9274
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Future Value

Related Facts

  • Screening and treatment for eye disease in all type 2 diabetes patients would result in an estimated net savings of 94,304 person-years of sight.  
  • Multifoca electroretinogram (mFERG) measures show abnormal function of the retina early in–and even prior to–diabetic retinopathy onset and could enhance monitoring of the early stages of disease progression in individuals.  
  • Multifocal electroretinogram (mFERG) and flicker perimetry show abnormal function in the central macula in early ag-related macular degeneration (AMD) and could enhance monitoring of the disease progression in individuals.  
  • The prevalence of age-related macular degeneration (AMD) in the 40 and older population has decreased from an estimated 9.4% from 1988 to 1994, to 6.5% for 2005 to 2008.  
  • Current treatments for proliferative diabetic retinopathy have reduced the rate of blindness within 5 years from 50% to less than 5%.